Screening compound: C40H47N3O8 (K087-0419)

Screening compound: C<sub>40</sub>H<sub>47</sub>N<sub>3</sub>O<sub>8</sub> (K087-0419)
Screening compound: C<sub>40</sub>H<sub>47</sub>N<sub>3</sub>O<sub>8</sub> (K087-0419) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C40H47N3O8 (K087-0419)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K087-0419

Molecular Formula

C40H47N3O8 (C40 H47 N3 O8)

Compound Name

N-[(1Z)-1-{N'-[(E)-[3a,5a,7-trihydroxy-11a-methyl-1-(5-oxo-2,5-dihydrofuran-3-yl)-hexadecahydro-1H-cyclopenta[a]phenanthren-9a-yl]methylidene]hydrazinecarbonyl}-2-(4-methoxyphenyl)eth-1-en-1-yl]benzamide

IUPAC name

N-[(1Z)-1-{N'-[(E)-[(3bR7R9bS)-3a5a7-trihydroxy-11a-methyl-1-(5-oxo-25-dihydrofuran-3-yl)-hexadecahydro-1H-cyclopenta[a]phenanthren-9a-yl]methylidene]hydrazinecarbonyl}-2-(4-methoxyphenyl)eth-1-en-1-yl]benzamide

SMILES

CC(CC[C@@H]([C@H]1CCC2(C[C@@H](CC3)O)O)C23/C=N/NC(/C(/NC(c2ccccc2)=O)=C/c(cc2)ccc2OC)=O)(C(CC2)C(CO3)=CC3=O)C12O

InChI

InChI=1S/C40H47N3O8/c1-37-16-13-31-32(40(37,49)19-15-30(37)27-21-34(45)51-23-27)14-18-39(48)22-28(44)12-17-38(31,39)24-41-43-36(47)33(20-25-8-10-29(50-2)11-9-25)42-35(46)26-6-4-3-5-7-26/h3-11,20-21,24,28,30-32,44,48-49H,12-19,22-23H2,1-2H3,(H,42,46)(H,43,47)/t28-,30?,31+,32+,37?,38?,39?,40?/m0/s1

InChI Key

ODMURZJQPKNHPV-WZJUFJHOSA-N

MDL Number (MFCD)

MFCD01539052

C40H47N3O8 (K087-0419) in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

ACE2 Library (3043 compounds)

CORONAVIRUS Library (20774 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Steroid-like Compounds (494 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cardiovascular
  • Metabolic
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Structure:
  • Cyclic compounds
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with C40H47N3O8 (K087-0419) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C40H47N3O8 (K087-0419)?
Check Price and Availability of C40H47N3O8 (K087-0419), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C40H47N3O8 (K087-0419) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C40H47N3O8 (K087-0419)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C40H47N3O8 (K087-0419)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C40H47N3O8 (K087-0419) available by request